MMCAP International’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

MMCAP International’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-599,321	Closed	-$6.05M	–	373
2022 Q4	$6.05M	Hold	599,321	–	–	0.61%	51
2022 Q3	$5.95M	Hold	599,321	–	–	0.47%	70
2022 Q2	$5.93M	Hold	599,321	–	–	0.48%	70
2022 Q1	$5.91M	Sell	599,321 -679	-0.1%	-$6.69K	0.35%	107
2021 Q4	$5.9M	Hold	600,000	–	–	0.37%	99
2021 Q3	$5.84M	Hold	600,000	–	–	0.41%	97
2021 Q2	$5.8K	Hold	600,000	–	–	0.28%	75
2021 Q1	$5.83M	Buy	+600,000	New	+$5.81M	0.57%	59

MMCAP International's BIOT Position: Q1 2023 in Review

MMCAP International sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 599,321 shares — an estimated $6.05M sold.

MMCAP International first reported a position in BIOT in Q1 2021 and held it in 8 quarters. The position peaked at $6.05M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

MMCAP International reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
MMCAP International sold 599,321 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $6.05M.
MMCAP International first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q1 2021 and held it in 8 quarters.
MMCAP International's Biotech Acquisition Company Class A Ordinary Shares position peaked at $6.05M in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on MMCAP International's 13F filing for Q1 2023, filed 11 May 2023.